Comment: Illumina's new PacBio remedies offer suggests it still harbors hope
DNA sequencer Illumina’s revised proposals to resolve UK antitrust concerns over its Pacific Biosciences acquisition suggests its hopes for the deal remain alive. The San Diego-based company has offered to permanently license thousands...To view the full article, register now.
Already a subscriber? Click here to view full article